237 related articles for article (PubMed ID: 17826782)
1. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease.
Wang J; Sim AS; Wang XL; Salonikas C; Moriatis M; Naidoo D; Wilcken DE
Atherosclerosis; 2008 Apr; 197(2):853-9. PubMed ID: 17826782
[TBL] [Abstract][Full Text] [Related]
2. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
[TBL] [Abstract][Full Text] [Related]
3. [Plasma asymmetric dimethylarginine and cystatin C levels in patients with coronary artery disease].
YOU L; ZHAO CX; SHAO JM; ZHANG L; WANG DW
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):798-800. PubMed ID: 21092647
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function.
Wilcken DE; Wang J; Sim AS; Green K; Wilcken B
J Inherit Metab Dis; 2006 Feb; 29(1):30-7. PubMed ID: 16601865
[TBL] [Abstract][Full Text] [Related]
5. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
Ronden RA; Houben AJ; Teerlink T; Bakker JA; Bierau J; Stehouwer CD; De Leeuw PW; Kroon AA
Am J Physiol Renal Physiol; 2012 Jul; 303(1):F149-56. PubMed ID: 22552932
[TBL] [Abstract][Full Text] [Related]
6. Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?
Işıklar OO; Barutcuoğlu B; Kabaroğlu C; Mutaf I; Özmen D; Bayındır O; Zoghi M; Uluer H
Clin Biochem; 2012 Nov; 45(16-17):1325-30. PubMed ID: 22750146
[TBL] [Abstract][Full Text] [Related]
7. Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function.
El-Khoury JM; Bunch DR; Hu B; Payto D; Reineks EZ; Wang S
Clin Biochem; 2016 Oct; 49(15):1140-1143. PubMed ID: 27452178
[TBL] [Abstract][Full Text] [Related]
8. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study.
Singh D; Whooley MA; Ix JH; Ali S; Shlipak MG
Nephrol Dial Transplant; 2007 Apr; 22(4):1087-92. PubMed ID: 17210589
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease.
Dandana A; Gammoudi I; Chalghoum A; Chahed H; Addad F; Ferchichi S; Miled A
J Clin Lab Anal; 2014 May; 28(3):191-7. PubMed ID: 24478035
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate.
Niccoli G; Conte M; Della Bona R; Altamura L; Siviglia M; Dato I; Ferrante G; Leone AM; Porto I; Burzotta F; Brugaletta S; Biasucci LM; Crea F
Atherosclerosis; 2008 Jun; 198(2):373-80. PubMed ID: 17983622
[TBL] [Abstract][Full Text] [Related]
11. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.
Bostom AG; Bausserman L; Jacques PF; Liaugaudas G; Selhub J; Rosenberg IH
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2241-4. PubMed ID: 10479668
[TBL] [Abstract][Full Text] [Related]
13. Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?
Zebrack JS; Anderson JL; Beddhu S; Horne BD; Bair TL; Cheung A; Muhlestein JB;
J Am Coll Cardiol; 2003 Jul; 42(1):57-63. PubMed ID: 12849660
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of plasma asymmetric dimethylarginine, homocysteine, and high-sensitive CRP levels in occult coronary artery disease: A multidetector-row computed tomography study.
Gürel E; Tigen K; Karaahmet T; Geçmen Ç; Mutlu B; Başaran Y
Herz; 2015 May; 40(3):495-501. PubMed ID: 24357092
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of serum cystatin C in predicting coronary artery disease.
Koc M; Batur MK; Karaarslan O; Abali G
Cardiol J; 2010; 17(4):374-80. PubMed ID: 20690093
[TBL] [Abstract][Full Text] [Related]
16. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C levels are associated with coronary artery disease and its severity.
Wang GN; Sun K; Hu DL; Wu HH; Wang XZ; Zhang JS
Clin Biochem; 2014 Nov; 47(16-17):176-81. PubMed ID: 25084128
[TBL] [Abstract][Full Text] [Related]
19. Parental history of premature coronary artery disease does not affect plasma levels of asymmetric dimethylarginine in young healthy adults.
Surdacki A; Zawiślak B; Rakowski T; Wieczorek-Surdacka E; Fedak D; Dubiel JS
Pol Arch Med Wewn; 2012; 122(10):487-93. PubMed ID: 23022711
[TBL] [Abstract][Full Text] [Related]
20. Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.
Dzielinska Z; Januszewicz A; Wiecek A; Prejbisz A; Zielinski T; Chudek J; Makowiecka-Ciesla M; Demkow M; Tyczynski P; Januszewicz M; Ruzyllo W; Naruszewicz M
Kidney Blood Press Res; 2010; 33(2):139-48. PubMed ID: 20516698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
